Univariate and multivariate analyses both identified IGF2BP2 expression, histological grade, T status, lymph node metastases, and disease stage as key independent prognostic factors impacting the overall survival of OSCC patients (Table 3). This evidence concerns the gene IGF2BP2 and metastatic malignant neoplasm in the lymph nodes.